Clinical Trial Update: Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease [EARLY_Phase 1]

View source ↗

Summary

A pediatric feasibility study is evaluating SGLT2 inhibitors for chronic kidney disease in children; the trial is in early phase and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Disease

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Chronic Kidney Diseases, Pediatric Kidney Disease | EARLY_Phase 1 | Status: RECRUITING